EdgePoint Investment Group Inc. - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 51 filers reported holding NOVELION THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

Quarter-by-quarter ownership
EdgePoint Investment Group Inc. ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$2,572,000
+14.4%
3,674,185
+18.5%
0.02%
+9.1%
Q3 2019$2,248,000
+1.8%
3,100,931
+9.5%
0.02%0.0%
Q2 2019$2,209,000
-25.8%
2,831,555
+16.9%
0.02%
-33.3%
Q1 2019$2,978,000
+49.6%
2,421,259
+2.2%
0.03%
+37.5%
Q4 2018$1,990,000
-69.4%
2,368,819
+7.9%
0.02%
-67.6%
Q3 2018$6,497,000
-19.6%
2,195,0630.0%0.07%
-26.7%
Q2 2018$8,078,000
+5.1%
2,195,0630.0%0.10%
-7.3%
Q1 2018$7,683,000
+12.3%
2,195,063
+0.1%
0.11%
+11.2%
Q4 2017$6,839,000
-6.3%
2,191,913
+111.1%
0.10%
-10.1%
Q3 2017$7,301,0001,038,5660.11%
Other shareholders

There were no reported owners of NOVELION THERAPEUTICS INC in Q3 2018.

NameSharesValueWeighting ↓
View complete list of NOVELION THERAPEUTICS INC shareholders